
The measles virus has been eliminated from the UK for the first time in the country’s history, according to the …

It’s good news for Roche as the company’s immunotherapy drug Tecentriq secures approval from the European Commission to be used …

A new research, funded by the British Heart Foundation, has led to the creation of a new heart attack test …

As a direct result of the UK’s referendum vote to leave the EU last year, the headquarters of the EMA, …

The destructive forces of Hurricane Maria have caused untold damage to the island nation, with a reported 13 people left …

Axovant Sciences was set up with just one drug candidate in its portfolio, and a risky one, at that. The …

Bicycle Therapeutics has moved to appoint industry veteran, Maria Koehler, to the position of Chief Medical Officer at the company. …

The FDA has been very public in its stance that it will look to gain the upper hand in bringing …

New research conducted by the Mayo Clinic in Minnesota has found participant groups for clinical trials in cancer underrepresent ethnic …

Operation Pangea X represents an anniversary, of sorts – as it stands as the 10th year of operations by Interpol …

Pfizer has moved to set up an entirely independent company to develop four of its own clinical-stage drug candidates. The …

The MHRA and NICE have been slowly improving the ways that the UK’s patients access medicines, but now Brexit threatens …

It was only last year that Allergan decided to cough up $1.7 billion to acquire Tobira Therapeutics, with the main …

Sanofi, along with its speciality care global business unit Sanofi Genzyme, are celebrating the news that NICE has passed its …

There has long been concern over cases of drug-resistant malaria emerging in Asia and now it has been revealed that …